Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Genotype and allele frequencies of APOA1 gene polymorphisms (−75 G/A and +83 C/T) among renal cancer cases and healthy controls

From: Apolipoprotein A1 -75 G/A and +83 C/T polymorphisms and renal cancer risk

Genotypes Cases (%) Controls (%) OR (95 %CI) P
  − 75 GG 108 (50.0) 119 (55.1) 1.00 (Reference)  
  − 75 GA 66 (30.6) 75 (34.7) 0.97 (0.64,1.48) 0.89
  − 75 AA 42 (19.4) 22 (10.2) 2.10 (1.18,3.75) 0.01
−75 G allele frequency 282 (65.3) 313 (72.5) 1.00 (Reference)  
−75 A allele frequency 150 (34.7) 119 (27.5) 1.40 (1.05,1.87) 0.02
  + 83 CC 145 (67.1) 136 (63.0) 1.00 (Reference)  
  + 83 CT 45 (20.8) 49 (22.7) 0.86 (0.54,1.38) 0.53
  + 83 TT 26 (12.1) 31 (14.3) 0.79 (0.44,1.39) 0.41
+83 C allele frequency 335 (77.5) 321 (74.3) 1.00 (Reference)  
+83 T allele frequency 97 (22.5) 111 (25.7) 0.84 (0.61,1.15) 0.27